Cover Image
市場調查報告書

色素性蕁麻疹 (肥胖細胞症,肥胖細胞腫):全球臨床實驗趨勢

Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 340875
出版日期 內容資訊 英文 65 Pages
訂單完成後即時交付
價格
Back to Top
色素性蕁麻疹 (肥胖細胞症,肥胖細胞腫):全球臨床實驗趨勢 Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Global Clinical Trials Review, H2, 2015
出版日期: 2015年08月31日 內容資訊: 英文 65 Pages
簡介

色素性蕁麻疹 (肥大細胞瘤) ,是肥胖細胞症局部性發病的罕見皮膚疾病。

本報告提供色素性蕁麻疹 (肥胖細胞症,肥胖細胞腫) 臨床實驗相關之最新趨勢分析,提供您各地區主要國家的臨床實驗數量,臨床實驗的各階段進展,實驗對象採用狀況,並彙整有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 色素性蕁麻疹 (肥胖細胞症,肥胖細胞腫)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:皮膚疾病治療藥臨床實驗上色素性蕁麻疹 (肥胖細胞症,肥胖細胞腫) 的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:皮膚疾病治療藥臨床實驗上色素性蕁麻疹 (肥胖細胞症,肥胖細胞腫) 的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

色素性蕁麻疹 (肥胖細胞症,肥胖細胞腫) 治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • C. H. Boehringer Sohn AG & Co. KG
    • Novartis AG
    • AB Science SA
    • United Pharmaceuticals SAS
    • Stemline Therapeutics, Inc.
    • Premier Research Group Limited
    • Patara Pharma, Inc.
    • NicOx S.A.
    • GlaxoSmithKline Plc
    • Alpha Bioresearch S.L.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Centre Hospitalier Regional Universitaire de Besancon
    • Charite - Universitatsmedizin Berlin
    • Floridsdorf Allergy Center
    • National Taiwan University Hospital
    • Yuzawa Medical Center

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2841CTIDB

GlobalData's clinical trial report, "Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Global Clinical Trials Review, H2, 2015" provides an overview of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) clinical trials scenario. This report provides top line data relating to the clinical trials on Urticaria Pigmentosa (Mastocytosis, Mastocytoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Urticaria Pigmentosa (Mastocytosis, Mastocytoma)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • AB Science SA
      • Clinical Trial Overview of AB Science SA
      • United Pharmaceuticals SAS
      • Clinical Trial Overview of United Pharmaceuticals SAS
      • Stemline Therapeutics, Inc.
      • Clinical Trial Overview of Stemline Therapeutics, Inc.
      • Premier Research Group Limited
      • Clinical Trial Overview of Premier Research Group Limited
      • Patara Pharma, Inc.
      • Clinical Trial Overview of Patara Pharma, Inc.
      • NicOx S.A.
      • Clinical Trial Overview of NicOx S.A.
      • GlaxoSmithKline Plc
      • Clinical Trial Overview of GlaxoSmithKline Plc
      • Alpha Bioresearch S.L.
      • Clinical Trial Overview of Alpha Bioresearch S.L.
    • Clinical Trial Overview of Top Institutes / Government
      • Centre Hospitalier Regional Universitaire de Besancon
      • Clinical Trial Overview of Centre Hospitalier Regional Universitaire de Besancon
      • Charite - Universitatsmedizin Berlin
      • Clinical Trial Overview of Charite - Universitatsmedizin Berlin
      • Floridsdorf Allergy Center
      • Clinical Trial Overview of Floridsdorf Allergy Center
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • Yuzawa Medical Center
      • Clinical Trial Overview of Yuzawa Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Region, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials, G7 Countries (%), 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials, E7 Countries (%), 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by AB Science SA, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by United Pharmaceuticals SAS, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Stemline Therapeutics, Inc., 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Premier Research Group Limited, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Patara Pharma, Inc., 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by NicOx S.A., 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alpha Bioresearch S.L., 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Regional Universitaire de Besancon, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Floridsdorf Allergy Center, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yuzawa Medical Center, 2015*

List of Figures

  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials, G7 Countries (%), 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Urticaria Pigmentosa (Mastocytosis, Mastocytoma) to Dermatology Clinical Trials, E7 Countries (%), 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Urticaria Pigmentosa (Mastocytosis, Mastocytoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top